(Q33889596)

29 July 2017

1 reference

title

Pediatric immunization for the future. Lyme disease vaccine and beyond (English)

1 reference

29 July 2017

0 references

Lutwick LI

1

1 reference

PubMed ID

10761515

29 July 2017

Abramson JM

series ordinal

2

1 reference

29 July 2017

1 April 2000

1 reference

Pediatric Clinics of North America

29 July 2017

1 reference

29 July 2017

47

1 reference

29 July 2017

465-79, viii

1 reference

29 July 2017

2

1 reference

Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Changes in heroin self-administration by a rhesus monkey after morphine immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Insect repellents: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

The public health impact of Lyme disease in Maryland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Western blotting in the serodiagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Childhood Lyme arthritis: experience in an endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

The underdiagnosis of neuropsychiatric Lyme disease in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Acquired resistance to Borrelia burgdorferi infection in the rabbit. Comparison between outer surface protein A vaccine- and infection-derived immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

7 January 2021

Lyme disease vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Maintaining and enhancing vaccine immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Smallpox as a Biological Weapon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Antibody-catalyzed degradation of cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Evolution of the type-1 (Th1)-type-2 (Th2) cytokine paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Serologic tests for Lyme disease. Interlaboratory variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

7 January 2021

Postexposure prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Expression of hepatitis B surface antigen in transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Expression of the rabies virus glycoprotein in transgenic tomatoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Immunization against rabies with plant-derived antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Gene therapy for peanut allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Potential of polymer microencapsulation technology for vaccine innovation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Recent advances in vaccine adjuvants for systemic and mucosal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Recombination between genes encoding major outer surface proteins A and B of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Induction of an outer surface protein on Borrelia burgdorferi during tick feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Antibody Testing in Lyme Disease A Comparison of Results in Four Laboratories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

7 January 2021

Lyme disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Vaccination onto bare skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Efficacy of human Lyme disease vaccine formulations in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Immunogenicity of transgenic plant-derived hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Laboratory evaluation in the diagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Prospects for a vaccine to prevent Lyme disease in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Clueless: parental knowledge of risk behaviors of middle school students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970218-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70218-2

1 reference

29 July 2017

1 reference

PubMed ID

10761515